Use of national linked healthcare, serology and viral genomic data to identify and characterise serious COVID breakthroughs post-booster / novel omicron vaccine

Project Details

StatusFinished
Effective start/end date1/10/2231/03/23

Funding

  • University of Birmingham: £142,413.77